Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06938789

How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study

The Impact of Bleeding on Delirium Outcomes in Older Patients With Hip Fractures: A Single-Blind, Randomized Controlled Trial - The IMPROVE-HIP Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
198 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to investigate whether early detection of bleeding and prompt blood transfusions can help prevent delirium in patients aged 75 and older who are admitted to the hospital with hip fractures. The main question the trial aims to answer is: • Do patients aged 75 and older with hip fractures benefit from quicker treatment of anaemia (low blood count) to reduce the risk of delirium? Researchers will compare early diagnosis and treatment of bleeding with standard care to determine if it helps lower the risk of developing delirium. Participants will: * Undergo blood tests and have their vital signs checked, as well as be screened for delirium three times a day for the first 48 hours after surgery. * Receive blood transfusions promptly if their haemoglobin levels drop below a specified threshold. * Have a follow-up visit at 30 days to assess their memory and overall quality of life. * Have another follow-up at 90 days to check for hospital readmissions and survival

Conditions

Interventions

TypeNameDescription
OTHERBlood TransfusionBlood transfusion is given without delay (within 4 hours) in case of hemoglobin below our threshold.
OTHERStandard careThese patients recieve our standard care including blood transfusion as usual. Vital parameters and delirium screening are collected three times a day.

Timeline

Start date
2025-04-01
Primary completion
2025-12-01
Completion
2026-03-01
First posted
2025-04-22
Last updated
2025-04-22

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06938789. Inclusion in this directory is not an endorsement.